| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | -0.085 | 0.03 |
| mRNA | spautin-1 | CTRPv2 | pan-cancer | AAC | -0.09 | 0.03 |
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | -0.089 | 0.03 |
| mRNA | QL-VIII-58 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.03 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | 0.087 | 0.03 |
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | 0.08 | 0.03 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | 0.084 | 0.03 |
| mRNA | VX-11e | GDSC1000 | pan-cancer | AAC | -0.083 | 0.03 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.04 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.079 | 0.04 |